Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Medical Economics
|
May 18, 2011
Economic impact of potential drug-drug interactions in opioid analgesics
Kent H Summers, R Amy Puenpatom, Niveda Rajan, et al.
Current Medical Research and Opinion
|
April 18, 2014
Use of prescription opioids with abuse-deterrent technology to address opioid abuse
Edward Michna, Noam Y Kirson, Amie Shei, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 16, 2010
Health economics perspective of the components of the cardiometabolic syndrome
Leonardo Tamariz, Ana Palacio, Yadong Yang, et al.
Journal of Managed Care Pharmacy : JMCP
|
November 6, 2008
Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database
Diana Brixner, Sameer R Ghate, Carrie McAdam-Marx, et al.
Journal of Medical Economics
|
June 4, 2014
Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans
Rami Ben-Joseph, Chi-Chang Chen, Ajita P De, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 4, 2002
Health-care resource use by asthmatics in Croatia
Stipe Oreskovic, Ivana Bozicevic, Miroslav Mastilica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 13, 2009
Impact of body mass index on the incidence of cardiometabolic risk factors in ambulatory care settings over 5 years or more
Qayyim Said, Carrie McAdam Marx, J Sanford Schwartz, et al.
Medical Care
|
August 13, 2016
Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain
Jill A Bell, Marco daCosta DiBonaventura, Edward A Witt, et al.
Journal of Medical Economics
|
February 27, 2018
Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective study
Aryana Sepassi, Francine Chingcuanco, Ronald Gordon, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 17, 2011
A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain
Todd Berner, Heather Thomson, Ann Hartry, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Medical Economics
|
May 18, 2011
Economic impact of potential drug-drug interactions in opioid analgesics
Kent H Summers, R Amy Puenpatom, Niveda Rajan, et al.
Current Medical Research and Opinion
|
April 18, 2014
Use of prescription opioids with abuse-deterrent technology to address opioid abuse
Edward Michna, Noam Y Kirson, Amie Shei, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 16, 2010
Health economics perspective of the components of the cardiometabolic syndrome
Leonardo Tamariz, Ana Palacio, Yadong Yang, et al.
Journal of Managed Care Pharmacy : JMCP
|
November 6, 2008
Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database
Diana Brixner, Sameer R Ghate, Carrie McAdam-Marx, et al.
Journal of Medical Economics
|
June 4, 2014
Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans
Rami Ben-Joseph, Chi-Chang Chen, Ajita P De, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 4, 2002
Health-care resource use by asthmatics in Croatia
Stipe Oreskovic, Ivana Bozicevic, Miroslav Mastilica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 13, 2009
Impact of body mass index on the incidence of cardiometabolic risk factors in ambulatory care settings over 5 years or more
Qayyim Said, Carrie McAdam Marx, J Sanford Schwartz, et al.
Medical Care
|
August 13, 2016
Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain
Jill A Bell, Marco daCosta DiBonaventura, Edward A Witt, et al.
Journal of Medical Economics
|
February 27, 2018
Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective study
Aryana Sepassi, Francine Chingcuanco, Ronald Gordon, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 17, 2011
A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain
Todd Berner, Heather Thomson, Ann Hartry, et al.
Page
of 4